This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New Strong Sell Stocks for August 11th
by Zacks Equity Research
CBAN, ICUI, and NVDA have been added to the Zacks Rank #5 (Strong Sell) List on August 11, 2022.
Colony Bankcorp (CBAN) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Colony Bankcorp (CBAN) delivered earnings and revenue surprises of -28.57% and 9.97%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for June 10th
by Zacks Equity Research
Teaser: ASX, CBAN, and RACE have been added to the Zacks Rank #5 (Strong Sell) List on June 10, 2022.
New Strong Sell Stocks for June 7th
by Zacks Equity Research
CNMD, CL, and CBAN have been added to the Zacks Rank #5 (Strong Sell) List on June 7, 2022.
New Strong Sell Stocks for June 3rd
by Zacks Equity Research
T, CL, and CBAN have been added to the Zacks Rank #5 (Strong Sell) List on June 3, 2022.
New Strong Sell Stocks for June 1st
by Zacks Equity Research
CBAN, CNMD, and FNF have been added to the Zacks Rank #5 (Strong Sell) List on June 1, 2022.
New Strong Sell Stocks for May 20th
by Zacks Equity Research
Teaser: CBAN, CHUY, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2022.
New Strong Sell Stocks for May 18th
by Zacks Equity Research
ALX, CBAN, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2022.
New Strong Sell Stocks for May 10th
by Zacks Equity Research
Teaser: ASX, ALCO, and CBAN have been added to the Zacks Rank #5 (Strong Sell) List on May 10, 2022.
Colony Bankcorp (CBAN) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Colony Bankcorp (CBAN) delivered earnings and revenue surprises of -7.50% and 7.75%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Colony Bankcorp (CBAN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Colony Bankcorp (CBAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colony Bankcorp (CBAN) Q4 Earnings Miss Estimates
by Zacks Equity Research
Colony Bankcorp (CBAN) delivered earnings and revenue surprises of -16.67% and 2.46%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
F.N.B. (FNB) Matches Q4 Earnings Estimates
by Zacks Equity Research
F.N.B. (FNB) delivered earnings and revenue surprises of 0% and 1.64%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Citigroup (C) Down on CIFS & Citi Asesores Sale to Insigneo
by Zacks Equity Research
In an effort to streamline its wealth business, Citigroup (C) has agreed to sell two non-bank subsidiaries, Citi International Financial Services and Citi Asesores de Inversion Uruguay, to Insigneo.
Northern Trust (NTRS) Teams Up With Accelex, Aids Digitization
by Zacks Equity Research
Northern Trust (NTRS) collaborates with Accelex to serve its Front Office Solutions clients with better efficiency by harnessing unstructured data on alternative investments.
Wells Fargo (WFC), HSBC to Use Blockchain Solution for FX Deals
by Zacks Equity Research
By using blockchain technology, Wells Fargo (WFC) shared settlement ledger will likely reduce settlement risks and costs related to processing FX transactions.
Citigroup (C) Expands Cash Management Product Suite in Europe
by Zacks Equity Research
Citigroup (C) expands its cash management solution across 14 new Europe markets to benefit from the wave of digital transformation in the treasury and FX risk management of corporate clients.
Here's Why You Should Hold Fifth Third (FITB) Stock for Now
by Zacks Equity Research
While efforts to expand the fee-income base on strategic investments will support Fifth Third's (FITB) revenue growth, elevated expenses might hinder bottom-line expansion in the upcoming period.
Here's Why You Should Hold Onto Comerica (CMA) Stock Now
by Zacks Equity Research
Despite bearing a concentrated loan portfolio, Comerica (CMA) is worth retaining in your portfolio on the back of its cost-control initiatives and improving organic growth.
Northern Trust (NTRS) Fortifies Relationship With Pendal
by Zacks Equity Research
Northern Trust (NTRS) tightens its partnership ties with Pendal, which will likely drive its top line and strengthen its position on the competitive landscape.
Citigroup (C) Partners With Taskize, Eases Workflow Woes
by Zacks Equity Research
Citigroup's (C) collaboration with Taskize is set to create an end-to-end operational workflow with counterparties, offering speedy and smoother counterparty resolution to Citi custody clients.
3 Reasons Why Colony Bankcorp (CBAN) Is a Great Growth Stock
by Zacks Equity Research
Colony Bankcorp (CBAN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's What Could Help Colony Bankcorp (CBAN) Maintain Its Recent Price Strength
by Zacks Equity Research
Colony Bankcorp (CBAN) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Colony Bankcorp (CBAN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Colony Bankcorp (CBAN) delivered earnings and revenue surprises of 90.00% and 0.72%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Colony Bankcorp (CBAN) Q3 Earnings Expected to Decline
by Zacks Equity Research
Colony Bankcorp (CBAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.